Primidone Tablets USP, 250mg recall — Lannett Company Inc. (Class III)

Lannett Company Inc. is recorded by the U.S. Food and Drug Administration (FDA) as recalling Primidone Tablets USP, 250mg — a Class III recall, initiated 2026-04-24 and posted to the FDA enforcement report on 2026-05-27, under recall number D-0533-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.”. From the product description, the form is tablets, the strength given is 250mg, the package is described as 100-count bottle and it is marked Rx only. 1 National Drug Code number is printed in the record: 0527-1231-01. Distribution is recorded as “USA Nationwide” — Nationwide (US), with the recalling firm on record in IN, United States. It is the only recall number the FDA has filed under event ID 98791. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0533-2026
FDA event ID 98791
Classification Class III (least serious regulatory tier)
Status Ongoing
Recalling firm Lannett Company Inc.
Recall initiated 2026-04-24
Reported by FDA 2026-05-27
Report lag 33 days from initiation to report
Distribution USA Nationwide — Nationwide (US)
Firm location on record IN, United States
Product description (source) Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1231-01.

Reason reported by FDA

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

13 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

6 identifying values matched by exact pattern in the 18-word product description above; each is a literal substring of it.

Product named Primidone Tablets USP
Form Tablets
Strength 250mg
Package 100-count bottle
NDC 0527-1231-01
Marketing category Rx only
Distributed by Lannett Company, Inc.

Other indexed recalls from Lannett Company Inc.

3 indexed records name Lannett Company Inc. as the recalling firm, across 3 FDA events, reported 2026-05-27 to 2026-07-08. A coverage-limited activity count over the ingested window, not a quality rating.

Recall recordRecall numberFDA tierStrength / formReported
Dextroamphetamine Saccharate, 5 mgD-0660-2026Class II5 mg · Extended-Release Capsules2026-07-08
Niacin Extended-release Tablets, 1,000 mgD-0584-2026Class II1,000 mg · Extended-Release Tablets2026-06-10

Other indexed recalls of primidone

6 indexed records name primidone as the recalled substance. Matching is on the product-name prefix of the FDA's own text, so other strengths and packages are included.

Recall recordRecall numberRecalling firmStrength / formReported
Primidone Tablets, 50 mgD-0585-2026Amneal Pharmaceuticals, LLC50 mg · Tablets2026-06-17
Primidone Tablets, 50 mgD-0534-2026Golden State Medical Supply Inc.50 mg · Tablets2026-05-27
Primidone Tablets, 250 mgD-0535-2026Golden State Medical Supply Inc.250 mg · Tablets2026-05-27
Primidone Tablets, 250 mgD-0536-2026Amerisource Health Services LLC250 mg · Tablets2026-05-27
Primidone Tablets, 50 mgD-0537-2026Amerisource Health Services LLC50 mg · Tablets2026-05-27

Reported in the same month (2026-05)

48 enforcement reports carry a report date in 2026-05; these 4 are the Class III ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
Busulfan Injection, 60 mgD-0539-2026Sagent PharmaceuticalsClass III2026-05-27
busPIRone Hydrochloride Tablets, 5 mgD-0511-2026Unichem Pharmaceuticals Usa Inc.Class III2026-05-13
Levocarnitine Injection, 1 g/5 mLD-0494-2026American Regent, Inc.Class III2026-05-06
Lidocaine Wound Gel, 0.13%D-0509-2026Water-jel Technologies, LLCClass III2026-05-06

Nearest Class III recalls by date

25 of 250 indexed records share the Class III tier; the 5 nearest to 2026-05-27 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
Nicotine Transdermal System Patch, 14 mgD-0550-2026Aveva Drug Delivery Systems, Inc.14 mg · Transdermal System2026-06-03
PRED MILD, 0.12%D-0551-2026Abbvie Inc.0.12% · Ophthalmic Suspension2026-06-03
Lidocaine HCl Injection, 2%D-0552-2026Eugia US LLC2% · Injection2026-06-10
Epinephrine Injection, 1mg/mLD-0581-2026Fresenius Kabi Usa, LLC1mg/mL · Injection2026-06-17
Premier, 8 mLD-0490-2026Premier Dental Products Co8 mL · Solution2026-04-29

Reading this record

Class III is the FDA's own severity tier for the recall action — 25 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 0527-1231-01 at the FDA source to confirm it is covered.

Namespace context: the Class III index (25 records) and the recall hub (250 records, 118 FDA events); Lannett Company Inc. (6 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0533-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0533-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-05-27
Ingested
2026-08-22
Record hash
eca3b5c5e09e7737

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.